Key facts
- Notable investors include Gongshang Capital, Xiamen Yingshu Private Equity Fund Management.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Boruijie Biotechnology
- ·The full record, as it builds
Funding rounds
No funding rounds for Boruijie Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Boruijie Biotechnology
Manufacturer of innovative medical devices designed to address personalised regeneration and repair of human soft tissues and organs. The company offers pioneering 3D-printed degradable medical implants and bio-intelligent manufacturing technology, enabling healthcare providers to advance precision medicine and improve human health and quality of life.
- Sector
- Healthcare
- HQ
- Shenzhen, China
- Founded
- 2023
- Website
- bioregeneration.com.cn/
- Ownership
- Privately Held (backing)
Boruijie Biotechnology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Boruijie Biotechnology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Boruijie Biotechnology in its N-PORT filings yet. We sweep new filings monthly.